Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-10

Clinical Trial Update: Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rasagiline for symptomatic fatigue in Parkinson's disease has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azilect (rasagiline)

Snippet

Sponsor: University of Florida | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-01-10